- About
-
Services
-
Offerings
- Offerings
- ADME and Bioanalytical Sciences
- Analytical Chemistry
- Assay Development
- Biochemical Assays
- Biophysical Assays
- Cell Based Assays
- Computational Chemistry
- Fragment and Compound Screening
- Integrated Drug Discovery Services
- Medicinal Chemistry
- Project Management and Consultancy Services
- Protein Expression and Purification Services
- Structural Biology
- Synthetic Chemistry
- Virtual screening
-
Research Phases
- Research Phases
- Hit Identification
- Hit to Lead
- Lead Optimisation
- Therapeutic Areas
- Target Classes
-
Approaches & Techniques
- Approaches & Techniques
- CDH (Target Gene Fragmentation)
- Cryogenic Electron Microscopy (Cryo-EM)
- Differential Scanning Fluorimetry (DSF) and nanoDSF Services
- Direct-to-Biology (D2B)
- Dynamic Light Scattering (DLS)
- eProtein Discovery
- Flow Cytometry
- Fragment Based Drug Discovery (FBDD)
- FragmentBuilder
- Grating-Coupled Interferometry
- High Throughput Screening
- Isothermal Titration Calorimetry (ITC)
- LeadBuilder
- PoLiPa (Membrane Protein Solubilisation)
- Spectral Shift and MST Services
- Structure Based Drug Design (SBDD)
- Surface Plasmon Resonance (SPR)
- X-ray Crystallography
-
Offerings
- Library
- News & Events
- Careers
Milner Therapeutics Symposium 2018
Cambridge, UK
Sunday, 30 Sep '18
The Milner Therapeutics Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments.
Dr Katie Chapman, Deputy Head of Chemistry, Dr Ray Boffey and our COO, Dr Tom Mander will be attending the event and will be sharing some of Domainex's work during the poster sessions.
Get in touch to find out more!
News
Start your next project with Domainex
Contact one of our experts today